Dietary approaches for atherosclerotic cardiovascular disease prevention in cerebral palsy

2021 ◽  
Author(s):  
Jessica R Iyer ◽  
Alexander C Razavi
Keyword(s):  
Cardiovascular Disease ◽  
Cerebral Palsy ◽  
Disease Prevention ◽  
Cardiovascular Disease Prevention ◽  
Atherosclerotic Cardiovascular Disease

scholarly journals Atherosclerotic Cardiovascular Disease Prevention

2014 ◽  
Vol 7 (5) ◽  
pp. 778-779 ◽  
Author(s):  
Andre R.M. Paixao ◽  
Colby R. Ayers ◽  
Jarett D. Berry ◽  
James A. de Lemos ◽  
Amit Khera
Keyword(s):  
Cardiovascular Disease ◽  
Disease Prevention ◽  
Cardiovascular Disease Prevention ◽  
Atherosclerotic Cardiovascular Disease

scholarly journals Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults

2020 ◽  
Vol 9 (24) ◽  
Author(s):  
Yi Guo ◽  
Christopher W. Wheldon ◽  
Hui Shao ◽  
Carl J. Pepine ◽  
Eileen M. Handberg ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Sexual Orientation ◽  
Primary Prevention ◽  
Disease Prevention ◽  
Sexual Minority ◽  
Online Survey ◽  
Cardiovascular Disease Prevention ◽  
Atherosclerotic Cardiovascular Disease ◽  
Increased Risk ◽  
Statin Use

Background Sexual minority, or lesbian, gay, and bisexual (LGB), individuals are at increased risk for cardiovascular disease attributable to elevated rates of health risk factors. However, although there is clear evidence that statin use can prevent cardiovscular disease in certain adult populations, no studies have examined how statins are being used among the LGB population. This study aimed to examine the prevalence and predictors of statin use among LGB and non‐LGB individuals using Facebook‐delivered online surveys. Methods and Results We conducted a cross‐sectional online survey about statin use in adults ≥40 years of age between September and December 2019 using Facebook advertising (n=1531). We calculated the prevalence of statin use by age, sexual orientation, and statin benefit populations. We used multivariable logistic regression to examine whether statin use differed by sexual orientation, adjusting for covariates. We observed a significantly lower rate of statin use in the LGB versus non‐LGB respondents (20.8% versus 43.8%; P <0.001) in the primary prevention population. However, the prevalence of statin use was not statistically different in the LGB versus non‐LGB respondents in the secondary prevention population. Adjusting for the covariates, the LGB participants were less likely to use statins than the non‐LGB respondents in the primary prevention population (odds ratio, 0.37; 95% CI, 0.19–0.70). Conclusions Our results are the first to emphasize the urgent need for tailored, evidence‐based cardiovascular disease prevention programs that aim to promote statin use, and thus healthy aging, in the LGB population.

Sign in / Sign up

Export Citation Format

Share Document